KIDNEY CANCER
Clinical trials for KIDNEY CANCER explained in plain language.
Never miss a new study
Get alerted when new KIDNEY CANCER trials appear
Sign up with your email to follow new studies for KIDNEY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Edited 'Living Drug' trial seeks to reboot immune system against tough cancers
Disease control Not yet recruitingThis is an early safety study for people with advanced lymphoma, myeloma, or certain solid tumors (like kidney cancer and sarcoma) that have come back after standard treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to recognize and a…
Matched conditions: KIDNEY CANCER
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for Tough-to-Treat kidney cancer? early trial tests novel drug combo
Disease control Not yet recruitingThis early-stage study aims to see if a new drug called HC-7366, when combined with standard immunotherapy drugs (nivolumab with or without ipilimumab), can help control advanced clear cell kidney cancer. It will enroll about 35 adults to test the safety of these combinations and…
Matched conditions: KIDNEY CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New drug combo aims to shrink tumors before surgeons operate
Disease control Not yet recruitingThis study is testing whether two experimental drugs, given alone or together before surgery, can safely shrink kidney tumors. The goal is to see if this pre-surgical treatment helps control the cancer. About 32 adults with a specific type of kidney cancer that can be surgically …
Matched conditions: KIDNEY CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
Mayo clinic aims to replace biopsies with urine test for kidney cancer
Diagnosis Not yet recruitingThis study aims to develop a non-invasive test using urine and blood samples to better identify and classify kidney cancer types. Researchers will analyze tiny particles in urine from 300 patients to find protein markers that distinguish between cancer subtypes. They will also ch…
Matched conditions: KIDNEY CANCER
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC